HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) has announced the issuance of inducement awards to seven new employees, including Eric Hyllengren, the newly appointed Chief Financial Officer. On July 15, 2025, the company granted options to purchase up to 890,950 Class A Ordinary Shares, with 672,000 options awarded to Hyllengren. These awards were approved by the Compensation Committee and the Board, granted outside the 2023 Equity Incentive Plan, and are in alignment with Nasdaq Listing Rule 5635(c)(4). The options will vest incrementally, with one fourth vesting on the vesting commencement date and the remainder vesting in equal quarterly installments, contingent upon continuous service.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.